翻訳と辞書
Words near each other
・ "O" Is for Outlaw
・ "O"-Jung.Ban.Hap.
・ "Ode-to-Napoleon" hexachord
・ "Oh Yeah!" Live
・ "Our Contemporary" regional art exhibition (Leningrad, 1975)
・ "P" Is for Peril
・ "Pimpernel" Smith
・ "Polish death camp" controversy
・ "Pro knigi" ("About books")
・ "Prosopa" Greek Television Awards
・ "Pussy Cats" Starring the Walkmen
・ "Q" Is for Quarry
・ "R" Is for Ricochet
・ "R" The King (2016 film)
・ "Rags" Ragland
・ ! (album)
・ ! (disambiguation)
・ !!
・ !!!
・ !!! (album)
・ !!Destroy-Oh-Boy!!
・ !Action Pact!
・ !Arriba! La Pachanga
・ !Hero
・ !Hero (album)
・ !Kung language
・ !Oka Tokat
・ !PAUS3
・ !T.O.O.H.!
・ !Women Art Revolution


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

Royal DSM : ウィキペディア英語版
DSM (company)

| foundation = 1902
| location = Heerlen, Netherlands
| key_people = Feike Sijbesma (CEO), Geraldine Matchett (CFO), Rob J. Routs (Chairman of the Supervisory Board)
| products = Nutritional and pharmaceutical ingredients, performance materials, chemicals for polymer manufacture
| homepage = (www.dsm.com dsm.com )
| industry = Chemicals
| revenue = 9.181 billion (2014)〔(【引用サイトリンク】title=Annual Report 2014 )
| operating_income = €619 million (2014)
| net_income = €145 million (2014)
| assets = €12.126 billion (end 2014)
| equity = €5.723 billion (end 2014)
| num_employees = 21,351 (end 2014)
| intl = yes
}}
DSM〔(【引用サイトリンク】title=Bloomberg Businessweek company profile )〕 (in full Koninklijke DSM N.V., or Royal DSM〔(【引用サイトリンク】title=DSM website )〕) is a Dutch-based multinational life sciences and materials sciences company. DSM's global end markets include food and dietary supplements,〔(【引用サイトリンク】title=DSM in Food, beverages & dietary supplements website )〕 personal care, feed,〔(【引用サイトリンク】title=DSM in Animal nutrition & health website )〕 medical devices,〔(【引用サイトリンク】title=DSM in Medical website )〕 automotive,〔(【引用サイトリンク】title=DSM in Automotive / transportation website )〕 paints,〔(【引用サイトリンク】title=DSM in Paint & coatings website )〕 electrical and electronics, life protection, alternative energy and bio-based materials.〔(【引用サイトリンク】title=DSM Bio-based Products & Services )〕 DSM and its associated companies deliver annual net sales of about €10 billion〔 with approximately 25,000 employees. The company is headquartered in the Netherlands, with locations on five continents. The company is listed on Euronext Amsterdam.
==History==
DSM was established in 1902 as a state-owned coal mining company. Through the years the company diversified into fertilizers and other chemicals. After 1965, when the Dutch government took the decision to phase out all mining operations in the Netherlands, this diversification was accelerated. By the time the last mine closed (in 1973), DSM had transformed into a chemical company. Since the 1990s DSM has transformed itself again, selling almost all of its commodity chemicals activities and becoming a Life Sciences & Materials Sciences company. This second transformation is the subject of the book by Hein Schreuder and Jean-Pierre Jeannet, titled "From Coal to Biotech: the transformation of DSM with business school support". 〔(From Coal to Biotech - The Transformation of DSM with Business School Support | Springer )〕
In 1989 the Dutch State floated 70% of its DSM shares on the Amsterdam Stock Exchange (now NYSE Euronext). The remaining 30% was floated in 1996, completing DSM’s privatization. In 1998 the company took over the Dutch food products and biotechnology group Gist-brocades. In 2000 it acquired the US company Catalytica Pharmaceuticals. In 2002 DSM sold its petrochemical division (naphtha crackers and polyolefin plants) to SABIC of Saudi Arabia. In 2003, DSM acquired the nutritional products business (including vitamins) of Roche. In 2005 NeoResins, the coating resins business of Avecia was purchased. In 2010 the Agro and Melamine business groups were sold to Orascom Construction Industries. In February 2011 DSM finalized its acquisition of US based Martek Biosciences Corporation. This acquisition was worth €700 million.〔(DSM CFO Schwalb: M&A Involves Fair Amount of 'Luck'. Available online. Retrieved on March 20, 2013. )〕 In August 2011 DSM transferred its anti-infectives business to a 50/50 global joint venture with Sinochem Group, named DSM Sinochem Pharmaceuticals.〔(【引用サイトリンク】title=DSM Sinochem Pharmaceuticals website )
In June 2012 DSM acquired Kensey Nash, a US-based biomedical company primarily focused on regenerative medicine, and the following month it acquired Ocean Nutrition Canada,〔(【引用サイトリンク】title=Ocean Nutrition Canada website )〕 the leading global provider of fish-oil derived nutritional products to the dietary supplement and food and beverage markets. In December 2012 DSM announced that it had acquired Cargill’s〔(【引用サイトリンク】title=Cargill website )〕 cultures and enzymes business, producing enzymes, polyunsaturated fatty acids (PUFAs), vitamins, cultures, probiotics, bio actives, preservation systems and tests. In the same month, DSM acquired US-based Fortitech. Fortitech〔(【引用サイトリンク】title=Fortitech website )〕 provides customized food ingredient blends for the food & beverage, infant nutrition and dietary supplements industries from six production sites located worldwide. In April 2013 DSM acquired Tortuga Companhia Zootécnica Agrária (Tortuga),〔(【引用サイトリンク】title=Tortuga website (Spanish/Portuguese) )〕 a Brazilian company manufacturing nutritional supplements for pasture raised beef and dairy cattle.
In March 2014 DSM and JLL Partners announced that DPx Holdings B.V. was operational. DPx Holdings, formed by combining DSM Pharmaceutical Products and Patheon Inc., is a provider of (CDMO) services, pharmaceutical products and select chemical products for other industries. DPx Holdings is 51% owned by JLL and 49% by Royal DSM. As a result, the former Pharma cluster (DSM Pharmaceutical Products and DSM Sinochem Pharmaceuticals) is excluded from DSM’s core EBITDA and the company reports on its investments in joint ventures as an associated account in accordance with the equity method rather than as ongoing business.
On 31 July 2015 DSM and CVC Capital Partners (CVC) announced that with the formation of a new company, ChemicaInvest B.V., a partnership for DSM’s activities in Polymer Intermediates (caprolactam and acrylonitrile) and Composite Resins had been finalized. ChemicaInvest is 65% owned by CVC and 35% by DSM. As a result, the former Polymer Intermediates (DSM Fibre Intermediates) cluster and Composite Resins business are excluded from DSM’s core EBITDA and the company reports on its investments in joint ventures as an associated account in accordance with the equity method rather than as ongoing business.〔http://www.dsm.com/corporate/media/informationcenter-news/2015/07/24-15-dsm-and-cvc-finalize-partnership-for-polymer-intermediates-and-composite-resins.html〕

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「DSM (company)」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.